Organism: Homo sapiens
Gene: 39616_at
Selected probe(set): 213933_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 39616_at (213933_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-7.095007
Number of Samples:22 / 4

Experimental	expO kidney cancer study 1 (papillary adenocarcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with papillary adenocarcinoma (NOS).
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-6.750437
Number of Samples:3 / 4

Experimental	expO kidney cancer study 1 (renal cell carcinoma, sarcomatoid; primary)
	Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma, sarcomatoid.
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-6.718193
Number of Samples:5 / 4

Experimental	expO kidney cancer study 1 (renal cell carcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma (NOS).
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-6.0316525
Number of Samples:19 / 3

Experimental	renal cell carcinoma study 5 (papillary type)
	Tumor tissue samples from the kidney of patients with papillary renal cell carcinoma (pRCC).
Control	normal kidney tissue (adult)
	Normal adult kidney tissue samples.

Relative Expression (log2-ratio):-5.8585825
Number of Samples:2 / 4

Experimental	expO kidney cancer study 1 (neoplasm, malignant; primary)
	Primary tumor tissue samples obtained from the kidney of patients with malignant neoplasm.
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-5.738393
Number of Samples:3 / 4

Experimental	expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; metastatic)
	Metastatic tumor tissue obtained from a patient with primary clear cell adenocarcinoma (NOS) of the kidney.
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-5.1009035
Number of Samples:2 / 3

Experimental	collecting duct carcinoma study 1
	Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC).
Control	normal kidney tissue (adult)
	Normal adult kidney tissue samples.

Relative Expression (log2-ratio):5.0282516
Number of Samples:2 / 3

Experimental	glioma study 16 (LN-319)
	Human glioma cell line LN319 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37°C and 5% CO2.
Control	normal astrocyte sample
	Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations.

Relative Expression (log2-ratio):-4.7871265
Number of Samples:4 / 3

Experimental	nephroblastoma study 2
	Tumor tissue samples from the kidney of patients with Wilms’ tumor.
Control	normal kidney tissue (adult)
	Normal adult kidney tissue samples.

Relative Expression (log2-ratio):4.6113224
Number of Samples:4 / 207

Experimental	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.
Control	expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with clear cell adenocarcinoma (NOS).